Globus Medical, Inc.

Equities

GMED

US3795772082

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 07:41:04 09/05/2024 pm IST 5-day change 1st Jan Change
61.44 USD -0.48% Intraday chart for Globus Medical, Inc. +21.64% +15.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
Sector Update: Health Care MT
Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards MT
Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating MT
Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating MT
Globus Medical Q1 Non-GAAP Earnings, Sales Rise; 2024 Guidance Boosted MT
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q1 Revenue $606.7M, vs. Street Est of $589.6M MT
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q1 EPS $0.72, vs. Street Est of $0.57 MT
Transcript : Globus Medical, Inc., Q1 2024 Earnings Call, May 07, 2024
Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024 CI
Globus Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
North American Morning Briefing : Stock Futures -2- DJ
BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60 MT
Globus Medical Insider Sold Shares Worth $405,730, According to a Recent SEC Filing MT
Atkore Insider Sold Shares Worth $2,195,228, According to a Recent SEC Filing MT
Truist Securities Adjusts Price Target on Globus Medical to $60 From $58, Keeps Hold Rating MT
Stifel Adjusts Globus Medical's Price Target to $64 From $61, Keeps Buy Rating MT
Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020. CI
Globus Medical Q4 Non-GAAP Earnings, Revenue Increase; Sets 2024 Guidance MT
Globus Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2024 CI
Transcript : Globus Medical, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q4 EPS $0.60, vs. Street Est of $0.61 MT
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q4 Revenue $616.5M, vs. Street Est of $608.2M MT
Globus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Globus Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Chart Globus Medical, Inc.
More charts
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
61.73 USD
Average target price
67.5 USD
Spread / Average Target
+9.35%
Consensus
  1. Stock Market
  2. Equities
  3. GMED Stock
  4. News Globus Medical, Inc.
  5. Globus Medical Launches Precice Bone Transport in Select Markets
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW